Fonte: PLOS Pathogens. Unidades: FMRP, FCFRP, ESALQ, ICB
Assuntos: COVID-19, INFLAMAÇÃO, PULMÃO
ABNT
SÁ, Keyla Santos Guedes de et al. Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19. PLOS Pathogens, v. 20, n. 6, p. 1-24, 2024Tradução . . Disponível em: https://doi.org/10.1371/journal.ppat.1012222. Acesso em: 09 nov. 2025.APA
Sá, K. S. G. de, Amaral, L. A., Rodrigues, T. S., Caetano, C. C. da S., Becerra, A. de M., Batah, S. S., et al. (2024). Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19. PLOS Pathogens, 20( 6), 1-24. doi:10.1371/journal.ppat.1012222NLM
Sá KSG de, Amaral LA, Rodrigues TS, Caetano CC da S, Becerra A de M, Batah SS, Lopes FT, Oliveira IM de, Lopes L de S, Almeida L de, Mota CM, Oliveira S dos S, Wada DT, Santos MK, Martins RB, Rosales RRC, Arruda Neto E de, Fabro AT, Zamboni DS. Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19 [Internet]. PLOS Pathogens. 2024 ; 20( 6): 1-24.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1371/journal.ppat.1012222Vancouver
Sá KSG de, Amaral LA, Rodrigues TS, Caetano CC da S, Becerra A de M, Batah SS, Lopes FT, Oliveira IM de, Lopes L de S, Almeida L de, Mota CM, Oliveira S dos S, Wada DT, Santos MK, Martins RB, Rosales RRC, Arruda Neto E de, Fabro AT, Zamboni DS. Pulmonary inflammation and viral replication define distinct clinical outcomes in fatal cases of COVID-19 [Internet]. PLOS Pathogens. 2024 ; 20( 6): 1-24.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1371/journal.ppat.1012222
